Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients
Open Access
- 30 January 2026
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 40 (2) , e70468
Abstract
Background and Aims: Post liver transplantation (LT) inflammation and fibrosis are clinical challenges that may affect long‐term outcomes. We aimed to investigate sCD163 as a biomarker of liver fibrosis in LT recipients and compare it with the Fibrosis 4 (FIB‐4) score and FibroScan. Methods: In the Danish Comorbidity in Liver Transplant Recipients study (DACOLT) we included 105 LT recipients at Aarhus University Hospital. We reviewed patient records and collected plasma for measurements of sCD163 and FIB‐4. Liver stiffness was assessed using FibroScan. Liver biopsies performed n = 33) were investigated by the Banff score and the METAVIR fibrosis score. Results: The majority (86%) had FibroScan with transient elastography ρ = 0.38, p < 0.001) and remained independently associated after multivariable adjustment (β = 0.14, p < 0.0002), corresponding to a 15.2% increase in liver stiffness per 1 mg/L increase in sCD163. In patients with liver biopsies, sCD163 levels were significantly higher in those with METAVIR stage F2–F4 compared to F0–F1 (5.04 vs. 2.35 mg/L, p = 0.018), and sCD163 correlated with histological fibrosis stage ( ρ = 0.40, p = 0.029). At a cutoff of 3.86 mg/L, sCD163 identified METAVIR F2–4 fibrosis with 80% sensitivity and 85% specificity (AUC = 0.94). Conclusions: In this cohort of LT recipients, sCD163 was associated with both liver stiffness and histological fibrosis. These findings support sCD163 as a promising noninvasive biomarker for detection and monitoring of liver fibrosis post‐LT, warranting evaluation in larger, prospective studies.Keywords
Funding Information
- Svend Andersen Fonden
- Kirsten og Freddy Johansens Fond
- Rigshospitalet
- Novo Nordisk Fonden
This publication has 49 references indexed in Scilit:
- Soluble CD163 from activated macrophages predicts mortality in acute liver failureJournal of Hepatology, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Progressive histological damage in liver allografts following pediatric liver transplantationHepatology, 2006
- Expression of CD163 in the liver of patients with viral hepatitisPathology - Research and Practice, 2005
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology, 2003
- Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infectionAmerican Journal of Gastroenterology, 2002
- Characterization of an enzyme-linked immunosorbent assay for soluble CD163Scandinavian Journal of Clinical and Laboratory Investigation, 2002
- Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single CenterAnnals of Surgery, 2000
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996
- Complications following percutaneous liver biopsyJournal of Hepatology, 1986